Fidelity Covington Trust. Holdings as of May 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Fidelity Revere Street TrustCash or money market | 10.27% | $4.21M | 4,206,098 |
| UCB SA | 4.73% | $2.26M | 6,605 |
| LIFESTANCE HEALTH GROUP INCLFST | 4.27% | $1.75M | 227,100 |
| DANAHER CORPDHR | 3.42% | $1.40M | 7,675 |
| 10X GENOMICS INCTXG | 3.11% | $1.27M | 45,000 |
| INTUITIVE SURGICAL INCISRG | 2.92% | $1.20M | 2,816 |
| COGENT BIOSCIENCES INCCOGT | 2.85% | $1.17M | 33,428 |
| ALNYLAM PHARMACEUTICALS INCALNY | 2.79% | $1.14M | 3,791 |
| ARGENX SEARGX | 2.78% | $1.14M | 1,365 |
| LEGEND BIOTECH CORPLEGN | 2.29% | $940.12K | 34,614 |
| UNITEDHEALTH GROUP INCUNH | 2.25% | $921.87K | 2,424 |
| BIO TECHNE CORPTECH | 2.24% | $919.18K | 17,786 |
| SARTORIUS STEDIM BIOTECH | 1.84% | $880.29K | 3,633 |
| ASCENDIS PHARMA A/S | 2.11% | $866.19K | 3,865 |
| EDWARDS LIFESCIENCES CORPEW | 2.11% | $864.70K | 10,000 |
| MODERNA INCMRNA | 2.11% | $862.73K | 18,282 |
| KYMERA THERAPEUTICS INCKYMR | 1.99% | $814.20K | 10,000 |
| XENON PHARMACEUTICALS INCXENE | 1.92% | $786.25K | 14,366 |
| HEARTFLOW INCHTFL | 1.89% | $774.31K | 24,994 |
| INSMED INCINSM | 1.79% | $735.01K | 6,875 |
| VEEVA SYS INCVEEV | 1.78% | $730.14K | 4,188 |
| VAXCYTE INCPCVX | 1.77% | $723.25K | 14,071 |
| REVOLUTION MEDICINES INCRVMD | 1.73% | $709.29K | 4,504 |
| CARIS LIFE SCIENCES INCCAI | 1.71% | $702.09K | 41,991 |
| CRINETICS PHARMACEUTICALS INC | 1.65% | $675.45K | 19,000 |
| AXSOME THERAPEUTICS INCAXSM | 1.57% | $645.29K | 2,752 |
| LONZA GROUP AG | 1.22% | $640.63K | 780 |
| CYTOKINETICS INCCYTK | 1.55% | $634.19K | 8,262 |
| VERACYTE INCVCYT | 1.54% | $631.20K | 13,621 |
| THERMO FISHER SCIENTIFIC INCTMO | 1.53% | $628.44K | 1,276 |
| BRIGHTSPRING HEALTH SERVICES INCBTSG | 1.53% | $628.33K | 10,187 |
| PRIVIA HEALTH GROUP INCPRVA | 1.48% | $604.84K | 28,119 |
| BOSTON SCIENTIFIC CORPBSX | 1.44% | $588.66K | 12,185 |
| NATERA INCNTRA | 1.43% | $584.11K | 2,615 |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 1.42% | $580.56K | 12,000 |
| GUARDANT HEALTH INCGH | 1.38% | $567.39K | 4,375 |
| STRYKER CORPSYK | 1.36% | $558.92K | 1,832 |
| VIRIDIAN THERAPEUTICS INCVRDN | 1.34% | $547.98K | 31,100 |
| ALIGNMENT HEALTHCARE INCALHC | 1.25% | $511.35K | 33,378 |
| NUVALENT INC | 1.21% | $497.20K | 4,504 |
| STOKE THERAPEUTICS INCSTOK | 1.18% | $484.36K | 15,670 |
| DISC MEDICINE INCIRON | 1.18% | $481.84K | 6,926 |
| DEXCOM INCDXCM | 1.18% | $481.74K | 6,533 |
| INSULET CORPPODD | 1.10% | $451.05K | 3,112 |
| ELI LILLY and COLLY | 1.07% | $436.48K | 395 |
| ENLIVEN THERAPEUTICS INCELVN | 1.03% | $423.52K | 10,703 |
| CYTOMX THERAPEUTICS INCCTMX | 0.98% | $403.45K | 112,069 |
| WAYSTAR HOLDING CORPWAY | 0.98% | $401.92K | 20,187 |
| IRHYTHM TECHNOLOGIES INCIRTC | 0.96% | $395.35K | 3,471 |
| KESTRA MEDICAL TECHNOLOGIES INC | 0.95% | $391.18K | 18,400 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.